Xiaoling Liu

Title: Innovations in Cancer Treatment by Xiaoling Liu

Introduction

Xiaoling Liu is an accomplished inventor based in Pearland, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent developments. His work focuses on utilizing oncolytic viruses in combination with gut microbiota to enhance therapeutic outcomes for cancer patients.

Latest Patents

Xiaoling Liu holds a patent for "Anti-cancer oncolytic virus combination therapies and elite responder selection platforms." This patent outlines therapeutic methods for administering gut microbiota and oncolytic viruses to a subject. The gut microbiota serves to pre-condition the subject's immune system to antitumor responses and augments the anticancer activity of the oncolytic virus. The patent also discusses combinations of gut microbiota and viruses for treating and preventing cancer. Furthermore, it provides methods for building elite responder selection platforms through hierarchical clustering analysis of genomic profiles for the human gut microbiome.

Career Highlights

Xiaoling Liu is associated with Suzhou Prajna Biotech Co., Ltd., where he continues to advance his research in cancer therapies. His innovative approaches have the potential to revolutionize how cancer is treated, making significant strides in personalized medicine.

Collaborations

Xiaoling Liu collaborates with talented individuals in his field, including Rebecca Hu and Minjie Hu. Their combined expertise contributes to the ongoing research and development of effective cancer therapies.

Conclusion

Xiaoling Liu's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His patented methods and collaborative efforts are paving the way for new therapeutic strategies that could significantly improve patient outcomes.